Contrasting systemic stabilities of the acyl and phenolic glucuronides of diflunisal in the rat

References

• Benet L. Z., Spahn H. Acyl migration and covalent binding of drug glucuronides—potential toxicity mediators. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext, London 1988; 261–269
   Google Scholar
• Caldwell J., Grubb N., Sinclair K. A., Hutt A. J., Weil A., Fournel-Gigleux S. Structural and stereochemical aspects of acyl glucuronide formation and reactivity. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext, London 1988; 185–192
   Google Scholar
• Dickinson R. G., King A. R. Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Therapeutic Drug Monitoring 1989; 11: 712–720
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Harland R. C., Ilias A. M., Rodgers R. M., Kaufman S. N., Lynn R. K., Gerber N. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Journal of Pharmacology and Experimental Therapeutics 1979; 221: 583–595
   Google Scholar
• Dickinson R. G., Hooper W. D., Eadie M. J. pH-Dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms. Drug Metabolism and Disposition 1984; 12: 247–252
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Kluck R. M., Hooper W. D., Patterson M., Chalk J. B., Eadie M. J. Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction. Epilepsia 1985; 26: 589–593
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Kluck R. M., Wood B. T., Eadie M. J., Hooper W. D. Impaired biliary elimination of β-glucuronidase-resistant ‘lucuronides’ of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers. Drug Metabolism and Disposition 1986; 14: 255–262
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., King A. R., Verbeeck R. K. Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulfate conjugates in bile-exteriorized and intact rats. Clinical and Experimental Pharmacology and Physiology 1989; 16: 913–924
   PubMed Web of Science ®Google Scholar
• Faed E. M. Decreased clearance of diflunisal in renal insufficiency—an alternative explanation. British Journal of Clinical Pharmacology 1980; 10: 185–186
   PubMed Web of Science ®Google Scholar
• Faed E. M. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews 1984; 15: 1213–1249
   PubMed Web of Science ®Google Scholar
• Hansen-Moller J., Dalgaard L., Hansen S. H. Reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of diflunisal and its glucuronides in serum and urine. Rearrangement of the 1-O-acylglucuronide. Journal of Chromatography 1987; 420: 99–109
   PubMed Web of Science ®Google Scholar
• Hansen-Moller J., Cornett C., Dalgaard L., Hansen S. H. Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide. Journal of Pharmaceutical and Biomedical Analysis 1988; 6: 229–240
   PubMed Web of Science ®Google Scholar
• Hyneck M. L., Munafo A., Benet L. Z. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide. Drug Metabolism and Disposition 1988; 16: 322–324
   PubMed Web of Science ®Google Scholar
• Levy G. Decreased body clearance of diflunisal in renal insufficiency—an alternative explanation. British Journal of Clinical Pharmacology 1979; 8: 601
   PubMed Web of Science ®Google Scholar
• Lin J. H., Hooke K. F., Yeh K. C., Duggan D. E. Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism. Journal of Pharmacology and Experimental Therapeutics 1985a; 235: 402–406
   PubMed Web of Science ®Google Scholar
• Lin J. H., Yeh K. C., Duggan D. E. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats. Drug Metabolism and Disposition 1985b; 13: 321–326
   PubMed Web of Science ®Google Scholar
• Lin J. H., Ulm E. H., Duggan D. E. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure. Journal of Pharmacology and Experimental Therapeutics 1986; 238: 978–984
   PubMed Web of Science ®Google Scholar
• Loewen G. R., Herman R. J., Ross S. G., Verbeeck R. K. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. British Journal of Clinical Pharmacology 1988; 26: 31–39
   PubMed Web of Science ®Google Scholar
• Loewen G. R., McKay G., Verbeeck R. K. Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate. Drug Metabolism and Disposition 1986; 14: 127–131
   PubMed Web of Science ®Google Scholar
• McKinnon G. E., Dickinson R. G. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Research Communications in Chemical Pathology and Pharmacology 1989; 66: 339–354
   PubMedGoogle Scholar
• Meffin P. J., Zilm D. M., Veenendaal J. R. Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 732–738
   PubMed Web of Science ®Google Scholar
• Musson D. G., Lin J. H., Lyon K. A., Tocco D. J., Yeh K. C. Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine. Journal of Chromatography 1985; 337: 363–378
   PubMed Web of Science ®Google Scholar
• Rowe B. J., Meffin P. J. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1984; 230: 237–241
   PubMed Web of Science ®Google Scholar
• Ruelius H. W., Kirkman S. K., Young E. M., Janssen F. W. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. Biological Reactive Intermediates, J. J. Koscis, D. J. Jollow, C. M. Witmer, J. O. Nelson, R. Snyder. Plenum, New York 1986; 431–442
   Google Scholar
• Sallustio B. C., Purdie Y. J., Birkett D. J., Meffin P. J. Effect of renal dysfunction on the individual components of the acyl glucuronide futile cycle. Journal of Pharmacology and Experimental Therapeutics 1989; 251: 288–294
   PubMed Web of Science ®Google Scholar
• Sinclair K. A., Caldwell J. The formation of β-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH. Biochemical Pharmacology 1982; 31: 953–957
   PubMed Web of Science ®Google Scholar
• Smith P. C., Hasegawa J., Langendijk P. N. J., Benet L. Z. Stability of acyl glucuronides in blood, plasma and urine: studies with zomepirac. Drug Metabolism and Disposition 1985; 13: 110–112
   PubMed Web of Science ®Google Scholar
• Smith P. C., McDonagh A. F., Benet L. Z. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. Journal of Clinical Investigation 1986; 77: 934–939
   PubMed Web of Science ®Google Scholar
• Tocco D. J., Breault G. O., Zacchei A. G., Steelman S. L., Perrier C. V. Physiological disposition and metabolism of 5-(2′,4′-difluorophenyl)salicyclic acid, a new salicylate. Drug Metabolism and Disposition 1975; 3: 453–466
   PubMed Web of Science ®Google Scholar
• Van Breemen R. B., Fenselau C. Acylation of albumin by 1-O-acyl glucuronides. Drug Metabolism and Disposition 1985; 13: 318–320
   PubMed Web of Science ®Google Scholar
• Verbeeck R. K., Dickinson R. G., Pond S. M. Biliary excretion of diflunisal conjugates in patients with T-tube drainage. European Journal of Clinical Pharmacology 1988; 34: 423–426
   PubMed Web of Science ®Google Scholar
• Verbeeck R. K., Tjandramaga T. B., Mullie A., Verbesselt R., Verperckmoes R., De Schepper P. J. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency. British Journal of Clinical Pharmacology 1979; 7: 273–282
   PubMed Web of Science ®Google Scholar
• Watt J. A., Dickinson R. G. The effect of diethyl ether, pentobarbitone and urethane anaesthesia on diflunisal conjugation and disposition in rats. Xenobiotica 1990a; 20: 289–301
   PubMed Web of Science ®Google Scholar
• Watt J. A., Dickinson R. G. Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions. Biochemical Pharmacology 1990b; 39: 1067–1075
   PubMed Web of Science ®Google Scholar
• Watt J. A., Dickinson R. G. Effects of blockage of urine and/or bile flow on diflunisal conjugation and disposition in rats. Xenobiotica 1990c; 20: 835–845
   PubMed Web of Science ®Google Scholar
• Weil A., Guichard J. P., Caldwell J. Interactions between fenofibryl glucuronide and human serum albumin or human plasma. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext, London 1988; 233–236
   Google Scholar